Kk Shah Hospitals Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of KK Shah Hospitals Ltd is ₹ 45 as of 21 Oct 15:30 . The P/E Ratio of KK Shah Hospitals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of KK Shah Hospitals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 25.38 crore on March 2025 . This represents a CAGR of -6.06% over 5 years The revenue of KK Shah Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of KK Shah Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of KK Shah Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of KK Shah Hospitals Ltd changed from 55.82 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 7 years .

About KK Shah Hospitals Ltd

KK Shah Hospitals Limited was incorporated under the name style of 'Jeevan Parv Healthcare Limited' on August 25, 2022 by the Central Registration Center, Manesar.
Subsequently, the Company changed its name from 'Jeevan Parv Healthcare Limited' to 'KK Shah Hospitals Limited' and a fresh certificate of incorporation on November 30, 2022 was issued by the Registrar of Companies, Gwalior, Madhya Pradesh.
The Company is engaged in the providing healthcare services. The Promoter, Dr. Kirti Kumar Shah started a clinic in Ratlam city in the year 1976 which further was transformed into a nursing home in the year 1991.
Subsequently, Dr. Kirti Kumar Shah established pediatrics care unit in 1991 under the name of 'Shah Maternity and Nursing Home'.
He started paediatric unit having Neonatal Intensive Care Unit (NICU) as an integral part of the Clinic in 1994.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of KK Shah Hospitals Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, KK Shah Hospitals Ltd or Transgene Biotek Ltd?

Market cap of KK Shah Hospitals Ltd is 30 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of KK Shah Hospitals Ltd and Transgene Biotek Ltd?

The stock performance of KK Shah Hospitals Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KK Shah Hospitals Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the KK Shah Hospitals Ltd stock price is INR ₹45.0. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of KK Shah Hospitals Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of KK Shah Hospitals Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.